Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Diseases: Page 2
Vesalius, GSK announce strategic alliance on neurodegenerative disease treatments
By
LabPulse.com staff writers
Biotech firm Vesalius Therapeutics announced a strategic collaboration with GSK aimed at the discovery and development of therapeutics for Parkinson's disease and another undisclosed neurodegenerative disease.
November 15, 2024
Biofidelity launches lung reagent for integrated tissue and liquid biopsy analysis
By
LabPulse.com staff writers
Biofidelity has launched its Aspyre Lung Reagents molecular diagnostic assay for identifying NSCLC biomarkers in both DNA and RNA.
November 14, 2024
Brain tumor collaborative offers $500K for practice changing liquid biopsy studies
By
LabPulse.com staff writers
The research should be practice-changing.
November 14, 2024
AMP reviews pitfalls of NGS testing for SARS-CoV-2
By
Liz Carey
Document offers key pre-analytical, analytical, and post-analytical considerations to help improve NGS-based surveillance programs.
November 15, 2024
Alveo Technologies to develop avian influenza A(H5) test with CDC
By
LabPulse.com staff writers
Under the agreement with the CDC, Alveo Technologies will develop a rapid diagnostic to detect and differentiate between influenza A and B and influenza A/H5, also known as the avian influenza subtype, in humans.
November 14, 2024
Mainz Biomed, Thermo Fisher collaborate on CRC screening test
By
LabPulse.com staff writers
Mainz Biomed and Thermo Fisher Scientific will jointly develop and potentially commercialize Mainz Biomed's next-generation colorectal cancer (CRC) screening test.
November 12, 2024
Veravas, Phanes Biotech to collaborate on Alzheimer's tau pathology assay
By
LabPulse.com staff writers
Clinical diagnostics developer Veravas and Phanes Biotech have announced that they will co-develop a blood-based Alzheimer’s disease (AD) tau pathology test.
November 8, 2024
Sunbird Bio shares new data on blood-based Parkinson's diagnostic
By
LabPulse.com staff writers
Biotech firm Sunbird Bio announced new data from a study demonstrating that Sunbird's technology could provide blood-based diagnosis of Parkinson's disease and other neurodegenerative diseases with a high level of accuracy.
November 1, 2024
Oxford Nanopore, U.K. government partner on pandemic early warning system
By
LabPulse.com staff writers
Oxford Nanopore and the U.K. government will create the world's first real-time biosurveillance system to monitor infectious disease outbreaks and assess the threat of emerging pandemics.
November 6, 2024
Inify, Karolinska Institutet partner on AI-driven prostate cancer diagnostics
By
LabPulse.com staff writers
Digital pathology firm Inify Laboratories is collaborating with scientists at the Karolinska Institutet in Stockholm on a project aimed at improving the precision of prostate cancer diagnosis through artificial intelligence (AI)-driven image analysis.
November 5, 2024
CMS Medicare fee schedule includes blood tests for CRC screening
By
LabPulse.com staff writers
In the 2025 Medicare Physician Fee Schedule final rule, the U.S. Centers for Medicare and Medicaid Services (CMS) updated coverage for a complete colorectal cancer (CRC) screening to include Medicare-covered blood-based biomarker CRC screening tests.
November 5, 2024
Alzheimer's panel validated in University of Pittsburgh study
By
LabPulse.com staff writers
A team at the University of Pittsburgh has validated a new blood test panel that can simultaneously measure over 100 Alzheimer's disease biomarkers.
November 4, 2024
Previous Page
Page 2 of 293
Next Page
